Goldman Sachs, an Ontario pension fund on the verge of a deal to buy a Covid-19 testing provider – .

0
53
Goldman Sachs, an Ontario pension fund on the verge of a deal to buy a Covid-19 testing provider – .


The infrastructure arm of Goldman Sachs Group Inc. and the Canadian pension fund Ontario Municipal Employees Retirement System are part of a group that is on the verge of reaching a deal to buy a majority stake in German supplier Amedes Holding GmbH medical diagnostic services, including Covid-19 testing, according to people familiar with the matter.
The deal would value the company at nearly $ 1.9 billion, including debt, people familiar with the matter said. Goldman and OMERS as well as AXA Investment Managers, the asset management business of the management of global insurer AXA SA, are buying the majority stake in European buyout company Antin Infrastructure Partners.
Based in Hamburg, Germany, privately-held Amedes provides diagnostic services to patients, resident physicians and clinics at more than 70 laboratories and practice sites in Germany and Belgium, according to its website. Its activity manages PCR tests which are used to diagnose Covid-19.
The acquisition would allow acquirers to benefit from strong demand for PCR diagnostic services. However, this activity could risk slowing down if the deployment of vaccines hinders the spread of the virus.
Write to Ben Dummett à [email protected]

LEAVE A REPLY

Please enter your comment!
Please enter your name here